Literature DB >> 25783511

The impact of DaTscan in the diagnosis of Parkinson disease.

Isis Gayed1, Usha Joseph, Mina Fanous, David Wan, Mya Schiess, William Ondo, Kyoung-Sook Won.   

Abstract

PURPOSE: The aim of this study was to evaluate the impact of DaTscan in a heterogeneous group of patients with movement disorders as well as the degree of confidence in scan findings between different readers. PROCEDURES: A retrospective evaluation of consecutive patients who underwent DaTscan during 1 year was performed. The patients' demographics, symptoms, duration, clinical diagnosis, and medications were collected. The scan findings were categorized by 2 blinded observers on a semiquantitative scale as follows: 0, normal; 1, mild; 2, moderate; 3, marked; and 4, absent uptake for each of the caudate heads and putamina separately. A correlation of the scan findings with the clinical symptoms and diagnosis as well as interobserver agreement was performed. Disagreement was considered when a difference greater than 2 in more than 1 area of the basal ganglia was recorded. Descriptive statistics and κ test for interobserver agreement were used for data analysis.
RESULTS: Fifty-seven patients were included (mean age, 63.4 years; 29 men, 28 women). Clinical diagnosis of Parkinson disease (PD) was certain in 26 and uncertain in 31 patients. DaTscan was markedly abnormal in 24 (92%) of 26 patients with certain clinical diagnosis of PD and normal in the remaining 2 (8%). In 31 patients with uncertain diagnosis, 15 (48%) had markedly abnormal scans, 5 (16%) had mild abnormalities, and 11 (36%) had normal scans. Each of the sensitivity and positive predictive value of DaTscan in patients who had certain clinical diagnosis of PD (26 patients) is 92%. Interobserver agreement occurred in 52 (91%) of 57 scans and disagreement in 5 (9%) of 57 (κ = 0.82). There was also a good correlation with laterality of symptoms in 32 (82%) of 39 positive studies.
CONCLUSIONS: Markedly abnormal DaTscan is confirmed as the diagnostic pattern for PD. This pattern helps confirm the diagnosis in patients with unclear clinical diagnosis. Good interobserver agreement is easily obtained in reading DaTscans.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25783511     DOI: 10.1097/RLU.0000000000000766

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  8 in total

Review 1.  Nuclear Imaging in the Diagnosis of Clinically Uncertain Parkinsonian Syndromes.

Authors:  Ralph Buchert; Carsten Buhmann; Ivayla Apostolova; Philipp T Meyer; Jürgen Gallinat
Journal:  Dtsch Arztebl Int       Date:  2019-11-01       Impact factor: 5.594

2.  Longitudinal striatal dopamine transporter binding and cerebrospinal fluid alpha-synuclein, amyloid beta, total tau, and phosphorylated tau in Parkinson's disease.

Authors:  Fardin Nabizadeh; Kasra Pirahesh; Elham Ramezannezhad
Journal:  Neurol Sci       Date:  2022-10-13       Impact factor: 3.830

3.  Characterizing structural neural networks in de novo Parkinson disease patients using diffusion tensor imaging.

Authors:  S Nigro; R Riccelli; L Passamonti; G Arabia; M Morelli; R Nisticò; F Novellino; M Salsone; G Barbagallo; A Quattrone
Journal:  Hum Brain Mapp       Date:  2016-07-28       Impact factor: 5.038

4.  Analysis of the Effect of Dopamine Transporter Scan on the Diagnosis and Management in a Tertiary Neurology Center.

Authors:  Shakya Bhattacharjee; Vijayashankar Paramanandam; Atrayee Bhattacharya
Journal:  Neurohospitalist       Date:  2019-02-14

5.  Task Specific Tremor Subsequently Developing into Parkinson's Disease: Case Series.

Authors:  Vindhya Koneru; William G Ondo
Journal:  Mov Disord Clin Pract       Date:  2020-11-17

6.  Impact of DaTscan Imaging on Clinical Decision Making in Clinically Uncertain Parkinson's Disease.

Authors:  Jonathan R Isaacson; Salima Brillman; Nisha Chhabria; Stuart H Isaacson
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

7.  Differences in cause and 12-month follow-up outcome of parkinsonian symptoms in depressed older adults treated with antipsychotics: a case series.

Authors:  Anastasios Politis; Nikolaos Kokras; Michael Souvatzoglou; Kostas Siarkos; Panagiotis Toulas; Constantin Potagas; Theodoros Hatzipanagiotou; Georgios Limouris; Panagiotis Alexopoulos
Journal:  BMC Psychiatry       Date:  2021-06-03       Impact factor: 3.630

8.  DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers.

Authors:  Moran Artzi; Einat Even-Sapir; Hedva Lerman Shacham; Avner Thaler; Avi Orr Urterger; Susan Bressman; Karen Marder; Talma Hendler; Nir Giladi; Dafna Ben Bashat; Anat Mirelman
Journal:  PLoS One       Date:  2017-04-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.